Reply to letter to the editor: “Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China” (Letter)
File version
Author(s)
Sarno, M
Araujo Júnior, E
Da Silva Costa, F
Barini, R
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
Dear Editor,
It was with great interest that we read and analyzed the letter to the editor of Xiang et al. The authors presented initial outcomes on the safety of lymphocyte immunotherapy (LIT) in a group of patients diagnosed with alloimmune recurrent miscarriage (RM) during November 1, 2019–January 17, 2020 in Center of Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology.
Journal Title
Archives of Gynecology and Obstetrics
Conference Title
Book Title
Edition
Volume
304
Issue
2
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Immunology
Persistent link to this record
Citation
Cavalcante, MB; Sarno, M; Araujo Júnior, E; Da Silva Costa, F; Barini, R, Reply to letter to the editor: “Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China”, Archives of Gynecology and Obstetrics (Letter), 2021, 304 (2), pp. 571-572